IC
KRRO icon

IEQ Capital’s Korro Bio KRRO Stock Holding History

IEQ Capital’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280K Buy
21,246
+8,469
+66% +$105K ﹤0.01% 1677
2026
Q1 		$145K Buy
+12,777
New +$141K ﹤0.01% 1754

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

IEQ Capital's KRRO Position: Q2 2026 in Review

IEQ Capital increased its Korro Bio (KRRO) stake by 66% in Q2 2026, buying an estimated $105K and bringing the position to 21,246 shares worth $280K. The position accounts for ﹤0.01% of the portfolio, ranked #1677.

IEQ Capital first reported a position in KRRO in Q1 2026 and has held it in 2 quarters since. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • IEQ Capital held 21,246 shares of Korro Bio worth $280K as of Q2 2026.
  • IEQ Capital bought 8,469 Korro Bio shares in Q2 2026, an estimated $105K.
  • Korro Bio made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1677 holding.
  • IEQ Capital first reported a position in Korro Bio in Q1 2026 and has held it in 2 quarters since.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.